🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Status
Terminated
Location
Diabeteszentrum Oldenburg
Start Date
2018-02-19
Trial ID
NCT03419624
Obesity is a medical condition which increases the risk of other diseases, ...
Status
Completed
Location
Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital
Start Date
2014-12
Trial ID
NCT02313220
Treatments Being Tested
The study is a randomised double blind placebo control cross over trial wit...
Status
Completed
Location
CEDAR, Royal Surrey County Hospital
Start Date
2018-09-20
Trial ID
NCT04219124
Treatments Being Tested
This study evaluates the metabolomics changes associated with dapagliflozin...
Status
Completed
Location
Virgen de la Victoria University Hospital. Endocrinology Department
Start Date
2019-05-12
Trial ID
NCT03919656
Treatments Being Tested
The study was an open-label, randomized, single-dose, two-period, two-seque...
Status
Completed
Location
PT Equilab International
Start Date
2023-03-08
Trial ID
NCT06127212
This study aims to determine whether dapaglfiflozin 12-week administration ...
Status
Completed
Location
Department of Nephrology
Start Date
2022-10-18
Trial ID
NCT04930549
To assess whether the addition of dapagliflozin to semaglutide and insulin ...
Status
Active Not Recruiting
Location
Diabetes and Endocrinology Research Center of WNY
Start Date
2019-05-01
Trial ID
NCT03899402
Treatments Being Tested
A Phase III, single-centre, randomized, 2-arm, parallel-group, double blind...
Status
Completed
Location
Center For Endocrine and Metabolic Diseases - Catholic University
Start Date
2017-12-01
Trial ID
NCT03313752
Treatments Being Tested
The aim of this study is to demonstrate bioequivalence of fixed dose combin...
Status
Completed
Location
Research Site
Start Date
2016-03-30
Trial ID
NCT02722239
Treatments Being Tested
Background: Inhibiting the sodium-glucose cotransporter-2 (SGLT2) has been ...
Status
Completed
Location
Steno Diabetes Center Copenhagen
Start Date
2020-02-01
Trial ID
NCT04193566
Treatments Being Tested